Acute Myocardial Infarction (AMI): Clinical Trials

79 trials for Acute Myocardial Infarction (AMI), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 24 recruiting, 18 not yet recruiting, 6 active not recruiting. 27 Not applicable, 6 Phase 2, 6 Phase 4, 5 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable27Recruiting 12, Completed 8, Not yet recruiting 5, Active not recruiting 2
Phase 26Not yet recruiting 4, Completed 1, Recruiting 1
Phase 46Not yet recruiting 3, Completed 2, Recruiting 1
Phase 35Completed 2, Recruiting 2, Active not recruiting 1

Follow Acute Myocardial Infarction (AMI): new trials by email Literature Review of Acute Myocardial Infarction (AMI) trials Research Report on Acute Myocardial Infarction (AMI)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CRP Apheresis in Infarct-Related Cardiogenic Shock
Selective C-reactive protein apheresis (PentraSorb®-CRP), Standard of care - Cardiogenic Shock, Acute Myocardial Infarction (AMI)
Not applicableRecruitingLeipzig Heart Science gGmbH502026-10-162026-10-27
Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic Shock
Microaxial flow pump (left ventricular assist device), Pulmonary artery catheter, Conventional hemodynamic monitoring - Cardiogenic Shock, Acute Myocardial Infarction (AMI)
Not applicableNot yet recruitingLeipzig Heart Science gGmbH7802026-10-012026-08-24
iLITE, Clinical Performance of the Angiolite™ Drug-Eluting Stent
Percutaneous Coronary Intervention - PCI Patients, de Novo Coronary Lesions
Not yet recruitingiVascular S.L.U.50002026-10-012026-10-21
Trends and Risk Factors of Adverse Cardiovascular and Cerebrovascular Events After Primary PCI
Collection of baseline characteristics - Acute Myocardial Infarction (AMI), Percutaneous Coronary Intervention (PCI)
RecruitingShanghai Zhongshan Hospital80002026-09-282026-09-29
Timing of Empagliflozin in Primary PCI: Pre-Reperfusion Versus Post-Reperfusion Versus Placebo in South Asian STEMI Patients
empagliflozin, Placebo - ST-elevation Myocardial Infarction (STEMI), Acute Myocardial Infarction (AMI)
Phase 2Not yet recruitingRehman Medical Institute - RMI4802026-09-012026-08-06
BRIDGE Trial: Embedding Consumer-grade mHealth Technologies Into Cardiac Rehabilitation
CBCR, BRIDGE mHealth intervention - Acute Myocardial Infarction (AMI), Percutaneous Coronary Intervention (PCI)
Not applicableNot yet recruitingUniversity of Illinois at Chicago302026-09-012026-08-03
Combined Antioxidant Therapy for Acute Myocardial Infarction
Combined antioxidant therapy, Placebo - Acute Myocardial Infarction (AMI), ST Elevation (STEMI) Myocardial Infarction
Phase 2Not yet recruitingUniversity of Chile462026-09-012026-08-20
SPIKE FLOW Endocardial Lead Safety and Performance Study
Lead insertion, lead removal - Acute Myocardial Infarction (AMI), Asystole
Not applicableRecruitingFIAB SpA1312026-08-072026-10-20
Prospective Cohort Study of Aging in Patients With Acute Myocardial Infarction
Acute Myocardial Infarction (AMI)
Not yet recruitingThe Affiliated Hospital of Hangzhou Normal University6002026-08-012026-07-15
Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
Guideline-recommended standard medical therapy alone, DES implantation plus guideline-recommended standard medical therapy - Acute Myocardial Infarction (AMI), ST-Segment Elevation Myocardial Infarction(STEMI)
Not applicableRecruitingHarbin Medical University20002026-07-132026-07-16
Early Ga-68 FAPI PET/MR After Acute Myocardial Infarction
68Ga-FAPI-04 PET/MR - Acute Myocardial Infarction (AMI)
RecruitingAnkara University252026-07-012026-07-27
Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction
Zastaprazan, Proton Pump Inhibitors (PPI) - Acute Myocardial Infarction (AMI), Gastrointestinal Bleeding
Phase 3RecruitingSamsung Medical Center50002026-06-232026-06-26
Machine Learning for Diagnosis of Occlusive MI in LBBB Patients
Digital 12-Lead ECG Analysis and Invasive Coronary Angiography - Acute Myocardial Infarction (AMI), Left Bundle Branch Block
RecruitingKonya City Hospital502026-06-012026-06-02
Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction
Recombinant Human Thymosin Beta 4 Injection (NL005), Placebo - Acute Myocardial Infarction (AMI), Acute Myocardial Infarction of Anterior Wall
Phase 2Not yet recruitingBeijing Northland Biotech. Co., Ltd.1892026-05-182026-05-14
TMS for Sympathetic Hyperactivity and Inflammation in Acute Myocardial Infarction
1-Hz repetitive transcranial magnetic stimulation (rTMS), Sham repetitive transcranial magnetic stimulation (sham rTMS) - Acute Myocardial Infarction (AMI)
Not applicableRecruitingBeijing Hospital1002026-05-172026-09-25
Effect of Montelukast on Inflammatory Markers and Cardiac Injury in Patients With Acute Myocardial Infarction
Montelukast 10 Mg Oral Tablet, placebo - Acute Myocardial Infarction (AMI)
Phase 2RecruitingOctober 6 University802026-04-202026-05-08
Prospective Lifespan Cohort of Myocardial Infarction
Acute Myocardial Infarction (AMI), Stable Angina
Not yet recruitingFujian Provincial Hospital60002026-04-102026-03-25
Safety and Efficacy of MiSaver (CB Cells) for Acute Myocardial Infarction, Phase II
Cord Blood Nucleated cells - Acute Myocardial Infarction (AMI)
Phase 2Not yet recruitingHONYA Medical Co Ltd1022026-03-302026-03-11
Construction and Analysis of a Risk Prediction Model for Acute Myocardial Infarction Based on Spatiotemporal Heterogeneous Data
Acute Myocardial Infarction Risk Prediction Model - Acute Myocardial Infarction (AMI)
Not yet recruitingBeijing Anzhen Hospital30002026-03-252026-03-27
A Study on the Development and Application of a Cardiac Rehabilitation Nursing Intervention Protocol for Patients With First-Episode Acute Myocardial Infarction Following PCI, Based on a Socio-Ecological Theory Model
A Cardiac Rehabilitation Nursing Intervention Program Based on the Social-Ecological Theory Model - Acute Myocardial Infarction (AMI), Percutaneous Coronary Intervention (PCI)
Not applicableCompletedJinzhou Medical University662026-03-142026-08-10

Showing 20 of 79. Sign in to see all of them.

Narrower conditions

Myocardial Infarction (11)  ·  ST Elevation Myocardial Infarction (10)  ·  Heart Failure (6)  ·  Non-ST Elevated Myocardial Infarction (5)  ·  Shock, Cardiogenic (5)  ·  Acute Coronary Syndrome (4)  ·  Angina, Unstable (4)  ·  Coronary Artery Disease (3)  ·  Coronary Disease (3)  ·  Heart Arrest (3)  ·  Tachycardia, Ventricular (3)  ·  Angina, Stable (2)  ·  Arrhythmias, Cardiac (2)  ·  Cardiovascular Diseases (2)  ·  Chest Pain (2)

Broader conditions

Heart Diseases (36)  ·  Pathological Conditions, Signs and Symptoms (36)  ·  Cardiovascular Diseases (35)  ·  Vascular Diseases (32)  ·  Pathologic Processes (31)  ·  Myocardial Ischemia (29)  ·  Infarction (22)  ·  Ischemia (22)  ·  Necrosis (22)  ·  Myocardial Infarction (11)  ·  Neurologic Manifestations (9)  ·  Signs and Symptoms (8)  ·  Pain (7)  ·  Angina Pectoris (5)  ·  Chest Pain (5)

Interventions

Aspirin (2)  ·  Standard of Care (2)  ·  dapagliflozin (2)  ·  empagliflozin (2)  ·  ziltivekimab (2)  ·  Adrenergic beta-Antagonists (1)  ·  Blood Specimen Collection (1)  ·  Cardiac Rehabilitation (1)  ·  Catheterization, Swan-Ganz (1)  ·  Cholesterol (1)  ·  Cholesterol, LDL (1)  ·  Clopidogrel (1)  ·  Counterpulsation (1)  ·  Device Lead Extraction (1)  ·  Dexrazoxane (1)

Sponsors

Shanghai Zhongshan Hospital (4)  ·  Assiut University (2)  ·  Leipzig Heart Science gGmbH (2)  ·  Nanjing First Hospital, Nanjing Medical University (2)  ·  Rohan Dharmakumar (2)  ·  The Affiliated Hospital of Xuzhou Medical University (2)  ·  Yonsei University (2)  ·  Angel Medical Systems (1)  ·  Ankara University (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Bach Mai Hospital (1)  ·  Beijing Anzhen Hospital (1)  ·  Beijing Hospital (1)  ·  Beijing Northland Biotech. Co., Ltd. (1)  ·  Brigham and Women's Hospital (1)

Countries

China (29)  ·  United States (10)  ·  Germany (5)  ·  South Korea (4)  ·  Spain (4)  ·  Turkey (Türkiye) (4)  ·  Australia (3)  ·  Denmark (3)  ·  France (3)  ·  India (3)  ·  Italy (3)  ·  Netherlands (3)  ·  Greece (2)  ·  Israel (2)  ·  Norway (2)

Top investigators

Chunfeng Dai, M.D. (2)  ·  Ahmad Yasa MD (1)  ·  Alfonso Jurado, MD, PhD (1)  ·  Anne Freund, PD Dr. med. (1)  ·  Ashraf S Niazi, MBBS, FRCP (1)  ·  Bo Yu, Ph.D. (1)  ·  Christian Hassager, Prof. DMSc (1)  ·  David H Smith, PhD (1)  ·  Dongying Zhang, Professor (1)  ·  Ernest Spitzer, MD (1)  ·  Herbert D Aronow, MD, MPH, MSCAI, FACC, MSVM (1)

Results publications

PMID 14744970, PMID 16182882, PMID 18332291, PMID 18442545, PMID 19064683, PMID 21742089, PMID 21878431, PMID 22357361, PMID 22920912, PMID 23599353, PMID 24576515, PMID 24621874, PMID 25066555, PMID 25861319, PMID 26800769, PMID 27436882, PMID 28304224, PMID 28830471, PMID 28886621, PMID 29226465, PMID 29496021, PMID 29546659, PMID 29643872, PMID 30842028, PMID 31081342, PMID 31535829, PMID 31623762, PMID 32222134, PMID 32272883, PMID 32692391, PMID 33092804, PMID 33157063, PMID 33769555, PMID 34449189, PMID 35115207, PMID 36326870, PMID 37993005, PMID 39115479, PMID 39152477, PMID 40014670, PMID 40058362, PMID 40418919, PMID 40913743, PMID 40939873, PMID 40945808, PMID 41360328, PMID 42499410, PMID 42609300, PMID 9133516

NIH funding

2023 (1)